Département des sciences cliniques, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, QC J2S 2M2, Canada.
Département des sciences cliniques, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, QC J2S 2M2, Canada.
J Dairy Sci. 2022 Nov;105(12):9917-9933. doi: 10.3168/jds.2021-21695. Epub 2022 Oct 4.
Active infectious bovine respiratory disease (BRD) is an infection of the airways that needs to be diagnosed correctly so that appropriate treatment can be initiated. The simplest and most practical test to detect active BRD in dairy calves raised for veal is the detection and interpretation of clinical signs by producers or technicians. However, the clinical scoring system currently available for veal calves lacks sensitivity and specificity, contributing to economic losses and high use of antimicrobials. An accurate and reliable batch-level test to detect active BRD is essential to tailor antimicrobial use and reduce economic losses in veal calves. The objective of this study was therefore to develop and validate a new veal calf respiratory clinical scoring system (VcCRS), including reliable clinical signs (cough, ear droop or head tilt) and increased rectal temperature to detect active BRD in batches of veal calves housed individually, and to describe the accuracy of the scoring system for identifying batches of veal calves to treat. During 2017 to 2018, clinical examination, thoracic ultrasonography (TUS) and a haptoglobin concentration (Hap) were prospectively performed on 800 veal calves housed individually in Québec, Canada. Deep nasopharyngeal swabs were performed on 250 veal calves. A Bayesian latent class model accounting for imperfect accuracy of TUS and Hap was used to obtain weights for the clinical signs and develop the VcCRS. The VcCRS was then validated externally in 3 separate data sets. Finally, the applicability of the VcCRS at batch level was determined. We found that calves with 2 of the following findings-cough, unilateral or bilateral ear droop or head tilt, or increased rectal temperature ≥39.7°C-were considered positive and had a 31% chance of having active BRD. Without at least 2 of these 2 findings, a calf had a 100% chance of not having active BRD. At the batch level, we found that a batch with ≥3 positive calves among 10 calves sampled 2 wk after arrival at the fattening unit had a 94% chance of having an active BRD prevalence ≥10%. A batch with <3 positive calves had a 95% chance of not having an active BRD prevalence ≥10%. In this study, we developed a simple individual and batch-level score that is reliable across examiners and performs effectively in the detection of active BRD in veal calves. The implementation of this VcCRS in the veal calf industry would promote the elaboration of a protocol tailoring antimicrobial use.
活性传染性牛呼吸道疾病(BRD)是一种气道感染,需要正确诊断,以便启动适当的治疗。检测用于小牛肉生产的犊牛中活性 BRD 的最简单和最实用的测试是生产者或技术人员检测和解释临床症状。然而,目前用于小牛肉犊牛的临床评分系统缺乏敏感性和特异性,导致经济损失和高抗生素使用率。一种准确可靠的批次水平检测活性 BRD 的方法对于定制抗生素的使用和降低小牛肉犊牛的经济损失至关重要。因此,本研究的目的是开发和验证一种新的小牛肉犊牛呼吸临床评分系统(VcCRS),包括可靠的临床症状(咳嗽、耳下垂或头部倾斜)和直肠温度升高,以检测单独饲养的小牛肉犊牛批次中的活性 BRD,并描述评分系统识别需要治疗的小牛肉犊牛批次的准确性。2017 年至 2018 年期间,在加拿大魁北克省对 800 头单独饲养的小牛肉犊牛进行了临床检查、胸部超声检查(TUS)和触珠蛋白浓度(Hap)的前瞻性检查。对 250 头小牛肉犊牛进行了深部鼻咽拭子检查。使用贝叶斯潜在类别模型,该模型考虑了 TUS 和 Hap 的不准确性,以获得临床症状的权重并开发 VcCRS。然后在 3 个独立的数据集中对 VcCRS 进行了外部验证。最后,确定了 VcCRS 在批次水平上的适用性。我们发现,出现以下 2 种情况的犊牛咳嗽、单侧或双侧耳下垂或头部倾斜,或直肠温度≥39.7°C,被认为是阳性,有 31%的可能性患有活动性 BRD。如果没有至少出现 2 种上述情况,则犊牛 100%没有活动性 BRD。在批次水平上,我们发现,在进入育肥场后 2 周内对 10 头犊牛进行采样,每个批次中有≥3 头阳性犊牛,该批次有 94%的可能性具有≥10%的活动性 BRD 流行率。如果每个批次中<3 头阳性犊牛,则该批次有 95%的可能性没有≥10%的活动性 BRD 流行率。在这项研究中,我们开发了一种简单的个体和批次评分,该评分在评估者之间具有可靠性,并且在检测小牛肉犊牛中的活性 BRD 方面表现出色。在小牛肉行业实施此 VcCRS 将促进制定定制抗生素使用的协议。